Articles from: Nature Reviews Drug Discovery (Nature.com)
 |
|
|
| Next Page
| |
| Obesity and diabetes: Adenosine kinase inhibitor increases β-cells (more) | 2012 03 31 |
|
|
|
| Fc receptor-targeted therapies for the treatment of inflammation, cancer an (more) | 2012 03 31 |
|
|
| Deal watch: Biogen acquires Stromedix to pursue novel fibrosis therapy (more) | 2012 03 31 |
|
|
| Neurodegenerative disease: RXR agonist reverses Alzheimer's disease (more) | 2012 03 31 |
|
| Hedgehog inhibitor gets landmark skin cancer approval, but questions remain (more) | 2012 03 31 |
|
| Neurological disorders: GM1 ganglioside improves motor function (more) | 2012 03 31 |
|
|
|
| Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviat (more) | 2012 03 31 |
|
|
|
|
|
|
|
|
|
|
| Neuromuscular disorders: Troponin activator improves muscle function (more) | 2012 03 31 |
|
|
|
|
| Maximizing the value of diagnostics in Alzheimer's disease drug development (more) | 2012 03 01 |
|
|
|
|
|
| Anticancer drugs: Angiogenesis drug does not improve chemotherapy (more) | 2012 03 01 |
|
|
|
|
|
|
|
| Cancer biomarkers: selecting the right drug for the right patient (more) | 2012 03 01 |
|
| Neurodegenerative disease: Harnessing virus-mediated mitochondrial protecti (more) | 2012 03 01 |
|
|
|
|
|
| Inflammatory bone loss: pathogenesis and therapeutic intervention (more) | 2012 03 01 |
|
|
|
|
|
|
| Next Page
| |
